(HY) Hyster-Yale Materials - Overview
Stock: Lift Trucks, Attachments, Aftermarket Parts, Fuel-Cell Engines, Port Equipment
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.81% |
| Yield on Cost 5y | 1.66% |
| Yield CAGR 5y | 2.67% |
| Payout Consistency | 96.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 46.3% |
| Relative Tail Risk | -10.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.57 |
| Alpha | -44.86 |
| Character TTM | |
|---|---|
| Beta | 1.068 |
| Beta Downside | 1.029 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.38% |
| CAGR/Max DD | 0.13 |
Description: HY Hyster-Yale Materials December 25, 2025
Hyster-Yale, Inc. (NYSE: HY) designs, engineers, manufactures, sells, and services lift trucks, attachments, and aftermarket parts through its Hyster and Yale brands, with additional product lines (UNISOURCE, PREMIER, Bolzoni, Auramo, Meyer) covering parts, forks, lift tables, and specialized equipment such as hydrogen fuel-cell stacks and rough-terrain forklifts.
Key operating metrics from the most recent fiscal year show revenue of roughly $2.2 billion, an adjusted EBITDA margin near 6.5 %, and a net-debt-to-EBITDA ratio of about 2.0×, indicating moderate leverage relative to peers. The company’s performance is tightly linked to macro-drivers like global e-commerce growth, which fuels demand for warehouse automation, and construction activity, which underpins sales of rough-terrain and high-capacity lift trucks.
Recent strategic moves include expanding its hydrogen-fuel-cell portfolio-aligned with the broader industrial shift toward zero-emission material-handling solutions-and a rebranding to Hyster-Yale, Inc. in June 2024, which may signal a refreshed market positioning. For a deeper quantitative view, you might explore HY’s metrics on ValueRay, where the platform aggregates recent earnings estimates and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 2.70m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.51 > 1.0 |
| NWC/Revenue: 10.39% < 20% (prev 9.62%; Δ 0.77% < -1%) |
| CFO/TA 0.05 > 3% & CFO 110.3m > Net Income 2.70m |
| Net Debt (396.7m) to EBITDA (102.9m): 3.86 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.7m) vs 12m ago -0.20% < -2% |
| Gross Margin: 18.14% > 18% (prev 0.21%; Δ 1793 % > 0.5%) |
| Asset Turnover: 184.9% > 50% (prev 196.5%; Δ -11.55% > 0%) |
| Interest Coverage Ratio: 1.68 > 6 (EBITDA TTM 102.9m / Interest Expense TTM 34.0m) |
Altman Z'' 2.16
| A: 0.20 (Total Current Assets 1.44b - Total Current Liabilities 1.04b) / Total Assets 2.06b |
| B: 0.17 (Retained Earnings 348.1m / Total Assets 2.06b) |
| C: 0.03 (EBIT TTM 57.0m / Avg Total Assets 2.12b) |
| D: 0.13 (Book Value of Equity 194.9m / Total Liabilities 1.51b) |
| Altman-Z'' Score: 2.16 = BBB |
Beneish M -2.92
| DSRI: 1.05 (Receivables 520.6m/542.5m, Revenue 3.91b/4.27b) |
| GMI: 1.16 (GM 18.14% / 21.03%) |
| AQI: 1.05 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 0.92 (Revenue 3.91b / 4.27b) |
| TATA: -0.05 (NI 2.70m - CFO 110.3m) / TA 2.06b) |
| Beneish M-Score: -2.92 (Cap -4..+1) = A |
What is the price of HY shares?
Over the past week, the price has changed by +9.06%, over one month by +11.53%, over three months by +6.79% and over the past year by -28.11%.
Is HY a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.5 | 0.1% |
| Analysts Target Price | 36.5 | 0.1% |
| ValueRay Target Price | 36.1 | -1.1% |
HY Fundamental Data Overview February 05, 2026
P/E Forward = 13.8313
P/S = 0.1577
P/B = 1.1219
P/EG = 1.61
Revenue TTM = 3.91b USD
EBIT TTM = 57.0m USD
EBITDA TTM = 102.9m USD
Long Term Debt = 252.2m USD (from longTermDebt, last quarter)
Short Term Debt = 215.6m USD (from shortTermDebt, last quarter)
Debt = 467.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 396.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.01b USD (617.3m + Debt 467.8m - CCE 71.1m)
Interest Coverage Ratio = 1.68 (Ebit TTM 57.0m / Interest Expense TTM 34.0m)
EV/FCF = 18.95x (Enterprise Value 1.01b / FCF TTM 53.5m)
FCF Yield = 5.28% (FCF TTM 53.5m / Enterprise Value 1.01b)
FCF Margin = 1.37% (FCF TTM 53.5m / Revenue TTM 3.91b)
Net Margin = 0.07% (Net Income TTM 2.70m / Revenue TTM 3.91b)
Gross Margin = 18.14% ((Revenue TTM 3.91b - Cost of Revenue TTM 3.20b) / Revenue TTM)
Gross Margin QoQ = 15.99% (prev 17.58%)
Tobins Q-Ratio = 0.49 (Enterprise Value 1.01b / Total Assets 2.06b)
Interest Expense / Debt = 2.29% (Interest Expense 10.7m / Debt 467.8m)
Taxrate = 34.16% (74.8m / 219.0m)
NOPAT = 37.5m (EBIT 57.0m * (1 - 34.16%))
Current Ratio = 1.39 (Total Current Assets 1.44b / Total Current Liabilities 1.04b)
Debt / Equity = 0.87 (Debt 467.8m / totalStockholderEquity, last quarter 536.0m)
Debt / EBITDA = 3.86 (Net Debt 396.7m / EBITDA 102.9m)
Debt / FCF = 7.41 (Net Debt 396.7m / FCF TTM 53.5m)
Total Stockholder Equity = 516.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.13% (Net Income 2.70m / Total Assets 2.06b)
RoE = 0.52% (Net Income TTM 2.70m / Total Stockholder Equity 516.5m)
RoCE = 7.42% (EBIT 57.0m / Capital Employed (Equity 516.5m + L.T.Debt 252.2m))
RoIC = 3.82% (NOPAT 37.5m / Invested Capital 982.9m)
WACC = 6.25% (E(617.3m)/V(1.09b) * Re(9.85%) + D(467.8m)/V(1.09b) * Rd(2.29%) * (1-Tc(0.34)))
Discount Rate = 9.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.65%
[DCF Debug] Terminal Value 78.90% ; FCFF base≈67.8m ; Y1≈44.5m ; Y5≈20.3m
Fair Price DCF = 13.05 (EV 583.1m - Net Debt 396.7m = Equity 186.4m / Shares 14.3m; r=6.25% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 23.25 | EPS CAGR: 30.47% | SUE: 1.75 | # QB: 1
Revenue Correlation: 53.17 | Revenue CAGR: 4.51% | SUE: 0.50 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-1.16 | Chg30d=N/A | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.46 | Chg30d=-3.905 | Revisions Net=-2 | Growth EPS=+43.1% | Growth Revenue=-0.8%